England’s NICE Backs Epidyolex For Seizures, Sativex For MS Spasticity

But New Guidance Rejects Cannabis-Based Drugs For Chronic Pain

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".